Physician profile
Lawrence I Mallon
NPI 1194788943
$5,332.15
in general payments reported to CMS, 2019-2025
26 companies · $1,184 in 2025
The $1,184 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,128 · 2020: $382 · 2021: $239 · 2022: $773 · 2023: $777 · 2024: $849 · 2025: $1,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,809.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $2,181.13 | 2019-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Medtronic, INC. | $711.14 | 2021-2025 | Hawkone, Ellipsys Vascular Access System, Concertotm |
| Janssen Pharmaceuticals, INC | $670.04 | 2019-2022 | |
| Inari Medical, INC. | $276.36 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $195.72 | 2023-2025 | Indigo System, Penumbra System, Ruby Coil |
| Lemaitre Vascular, INC. | $159.21 | 2019-2025 | Artegraft Vascular Graft |
| Genentech USA, INC. | $144.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $135.57 | 2024-2025 | |
| Ge Healthcare | $135.25 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $124.83 | 2019-2024 | Eliquis, Camzyos |
| Stryker Corporation | $101.82 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $75.86 | 2019-2020 | |
| Abbott Laboratories | $75.69 | 2024-2025 | Amplatzer Amulet |
| Surmodics, INC. | $74.18 | 2023-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Pounce Venous Thrombectomy System |
| Bard Peripheral Vascular, INC. | $48.18 | 2025 | Venovo |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $37.84 | 2025 | Eluvia |
| Edwards Lifesciences Corporation | $28.36 | 2024 | Sapien 3 Ultra Resilia |
| Angiodynamics, INC. | $24.99 | 2024 | Auryon Laser System 100-120 Vac |
| Mimedx Group, INC. | $24.30 | 2025 | |
| Solventum Corporation | $21.77 | 2024 | Prevena |
| W. L. Gore & Associates, INC. | $21.25 | 2023 | Gore Viabahn Endoprosthesis |
| Silk Road Medical, INC. | $19.18 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Smith+Nephew, INC. | $18.53 | 2019 | |
| Cook Medical LLC | $14.29 | 2023 | Cook |
| Reflow Medical INC | $12.42 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Mallon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.